数据中心
龙虎榜
大单追踪
资金流向
业绩预告
新股申购
行情中心
沪深市场
香港市场
美国市场
全球市场
行业风云
全球市场
向上 向下

   ACHV
-- -- --

今开：-- 昨收：-- 最高：-- 最低：--
成交量：--万手 市盈率：-- 总市值($)：-- 换手率：--
加入自选股

首页概览 公司概况 财务分析 高管介绍 股本结构 公司新闻

股本结构

单位：万股
公告日期 2024-02-29 2023-11-09 2023-08-14 2023-05-25 2023-05-09 2023-05-09
证券总股本 3425.19 2116.58 2110.58 2104.08 1804.08 1793.04
普通股本 3425.19 2116.58 2110.58 2104.08 1804.08 1793.04
优先股 未披露 未披露 未披露 未披露 未披露 未披露
其他 未披露 未披露 未披露 未披露 未披露 未披露
变动日期 2024-03-04 2023-09-30 2023-06-30 2023-05-30 2023-05-09 2023-03-31
注释：中概股证券总股本=普通股股本/ 存托凭证比例

历史变动

公告日期 变动后普通股本（万股） 变动后优先股（万股） 变动原因 变动日期
2024-02-29 3425.19 未披露
更多>>
Common stock offered 13,086,151 shares by the company
2024-03-04
2023-11-09 2116.58 未披露
更多>>
From June 30, 2023 to September 30, 2023 Shares issued as settlement with trade vendor
2023-09-30
2023-08-14 2110.58 未披露
更多>>
From March 31, 2023 to June 30, 2023 Shares issued - May 2023 private placement Restricted stock unit settlements withheld and retired to treasury Shares issued on exercise of warrants Restricted stock unit settlements
2023-06-30
2023-05-25 2104.08 未披露
更多>>
Common Stock Offered by the company 3,000,000 shares
2023-05-30
2023-05-09 1804.08 未披露 定期报告 2023-05-09
2023-05-09 1793.04 未披露
更多>>
From December 31, 2022 to March 31, 2023 Shares issued on exercise of warrants
2023-03-31
2023-03-16 1793.04 未披露 定期报告 2023-03-16
2023-03-16 1789.70 未披露
更多>>
From December 31, 2021 to December 31, 2022 Shares issued on exercise of warrants Shares issued from purchase agreement with Virtu Shares issued as settlement with trade vendor Restricted stock unit settlements Restricted stock unit settlements withheld and retired to treasury Shares issued under employee share purchase plan Shares issued - November 2022 private placement
2022-12-31
2022-11-14 971.07 未披露
更多>>
From June 30, 2022 to September 30, 2022 Shares issued under employee share purchase plan
2022-09-30
2022-08-11 968.19 未披露
更多>>
From March 31, 2022 to June 30, 2022 Shares issued from purchase agreement with Virtu Restricted stock unit settlements Restricted stock unit settlements withheld and retired to treasury
2022-06-30
2022-05-12 968.19 未披露 定期报告 2022-05-12
2022-04-21 947.51 未披露 定期报告 2022-04-01
2022-05-12 947.36 未披露
更多>>
From December 31, 2021 to March 31, 2022 Shares issued on exercise of warrants Shares issued from purchase agreement with Virtu Shares issued as settlement with trade vendor
2022-03-31
2022-03-10 946.08 未披露 定期报告 2022-03-10
2021-11-09 945.35 未披露
更多>>
From June 30, 2021 to September 30, 2021 Shares issued on exercise of warrants Restricted stock unit settlements
2021-09-30
2021-08-12 945.22 未披露
更多>>
From March 31, 2021 to June 30, 2021 Shares issued on exercise of warrants Shares issued as settlement with trade vendor
2021-06-30
2021-05-27 900.71 未披露
更多>>
1.Common stock offered 2,857,143 shares. 2.The number of shares of common stock to be outstanding after this offering is based on 6,149,917 shares of common stock outstanding as of March 31, 2021.
2021-05-27
2021-05-13 616.44 未披露 定期报告 2021-05-13
2021-05-13 614.99 未披露
更多>>
From December 31, 2020 to March 31, 2021 Shares issued on exercise of warrants Shares issued as settlement with trade vendor
2021-03-31
2021-03-11 614.99 未披露 定期报告 2021-03-11
2021-03-11 611.17 未披露
更多>>
from December 31, 2019 to December 31, 2020 Shares issued on exercise of warrants Shares issued - April 2020 Private placement Shares issued - July 2020 Registered direct offering Shares issued - August 2020 Public offering Shares issued - December 2020 Public offering Restricted stock unit settlements Shares issued on conversion of Series B preferred shares Adjustment of fractional shares on reverse stock split
2020-12-31
2020-12-07 576.64 未披露
更多>>
1.Common stock offered 2,150,000 shares. 2.The number of shares of common stock to be outstanding after this offering is based on 3,616,414 shares of common stock outstanding as of September 30, 2020.
2020-12-07
2020-11-12 361.77 未披露 定期报告 2020-11-12
2020-11-12 361.64 未披露
更多>>
From June 30, 2020 to September 30, 2020 Shares issued - July 2020 Registered Direct Offering Shares issued - August 2020 Public Offering Shares issued on exercise of warrants Restricted stock unit settlements Adjustment of fractional shares on reverse stock split
2020-09-30
2020-08-06 358.72 未披露 定期报告 2020-08-06
2020-07-30 229.93 未披露
更多>>
The Company’s board of directors has determined to set the reverse stock split ratio at 1-for-20. The effective date of the reverse stock split is July 31, 2020, and the shares will begin trading on a split-adjusted basis on July 31, 2020.
2020-07-31
2020-07-01 4598.69 未披露
更多>>
1.Common Stock Offered by the company 14,634,146 shares. 2.The number of shares of common stock to be outstanding after this offering in the table above is based on 31,352,764 shares of common stock outstanding as of March 31, 2020.
2020-07-01
2020-05-14 3751.54 未披露 定期报告 2020-05-14
2020-05-14 3135.28 未披露
更多>>
From December 31, 2019 to March 31, 2020 Shares issued on conversion of Series B preferred shares
2020-03-31
2020-05-14 3751.54 未披露 定期报告 2020-03-14
2020-03-13 3135.28 未披露 定期报告 2020-03-13
2020-03-13 2948.52 0.11
更多>>
from December 31, 2018 to December 31, 2019 Restricted stock unit settlements Shares issued - from purchase agreement with Lincoln Park Capital Shares issued - December 2019 public offering Shares issued on exercise of warrants Shares issued on conversion of Series A preferred shares Shares issued on conversion of Series B preferred shares
2019-12-31
2019-12-20 2068.03 0.63
更多>>
On December 19, 2019, the Company issued and sold (i) 12,577,504 shares of Common Stock (which includes 3,000,000 shares of Common Stock sold pursuant to the exercise of the Overallotment Option), (ii) 6,256 shares of Series B Preferred Stock and (iii) 23,000,000 Warrants (which includes 3,000,000 Warrants sold pursuant to the exercise of the Overallotment Option) pursuant to the Registration Statement and the Underwriting Agreement.
2019-12-19
2019-11-06 835.28 未披露 定期报告 2019-11-06
2019-11-06 810.28 未披露
更多>>
from June 30, 2019 to September 30, 2019 Restricted stock unit settlements
2019-09-30
2019-08-08 809.78 未披露
更多>>
from March 31, 2019 to June 30, 2019 Shares issued - from purchase agreement with Lincoln Park Capital Shares issued on exercise of warrants Shares issued on conversion of preferred shares
2019-06-30
2019-05-15 686.60 未披露 定期报告 2019-05-15
2019-05-15 672.12 0.06
更多>>
from December 31, 2018 to March 31, 2019 Restricted stock unit settlements
2019-03-31
2019-03-14 672.12 未披露 定期报告 2019-03-14
2019-03-14 672.11 0.06
更多>>
from December 31, 2017 to December 31, 2018 Restricted stock unit settlements Adjustment of fractional shares on reverse stock split Shares issued - from purchase agreement with Lincoln Park Capital Shares issued - June 2018 public offering Shares issued - October 2018 registered direct offering Shares issued on exercise of warrants Shares issued on conversion of preferred shares
2018-12-31
2018-11-07 672.11 未披露 定期报告 2018-11-07
2018-11-07 490.11 0.07 定期报告 2018-09-30
2018-08-16 455.10 未披露 定期报告 2018-07-30
2018-08-08 423.85 0.33 定期报告 2018-06-30
2018-05-24 129.08 未披露
更多>>
Achieve Life Sciences, Inc. (NASDAQ:ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisine for smoking cessation, today announced a reverse stock split of its shares of common stock at a ratio of 1-for-10. The reverse stock split will become effective on May 23, 2018, and shares will begin trading on the split-adjusted basis on the Nasdaq Capital Market under the Company's existing trading symbol "ACHV" at market open on May 24, 2018. The new CUSIP number following the reverse stock split will be 004468203.
2018-05-24
2018-05-09 1290.79 未披露 定期报告 2018-05-09
2018-03-01 1274.79 未披露 定期报告 2018-03-01
2018-03-01 1194.79 未披露
更多>>
from December 31, 2016 to December 31, 2017 Settlement of stockholder loans with related parties Shares issued on subscription Shares held by OncoGenex Shareholders Shares issued on conversion of Achieve common shares Shares cancelled on conversion of Achieve common shares Restricted Stock Unit Settlements Restricted Stock Unit Settlements withheld and retired to treasury Shares issues - Lincoln Park Capital
2017-12-31
2017-11-09 1194.77 未披露 定期报告 2017-11-09
2017-11-09 1148.28 未披露 定期报告 2017-09-30
2017-09-21 1094.68 未披露 定期报告 2017-08-31
2016-03-09 2981.30 未披露
更多>>
from December 31, 2014 to December 31, 2015 Stock option exercises Restricted Stock Unit Settlements Performance Restricted Stock Unit Settlements Performance Restricted Stock Unit Settlements withheld and retired to treasury Shares issues - Lincoln Park Capital
2015-12-31
2015-11-12 2980.43 未披露 定期报告 2015-11-12
2015-11-12 2979.89 未披露 定期报告 2015-09-30
2015-08-13 2979.18 未披露 定期报告 2015-08-13
2015-08-13 2443.37 未披露 定期报告 2015-06-30
2015-05-14 2376.26 未披露 定期报告 2015-05-14
2015-03-26 2267.91 未披露 定期报告 2015-03-26
2015-03-26 2262.14 未披露
更多>>
from December 31, 2013 to December 31, 2014 Stock option exercises Restricted Stock Unit Settlements Performance Restricted Stock Unit Settlements Performance Restricted Stock Unit Settlements withheld and retired to treasury Shares issued - ATM Financing Shares issued in July 2014 Financing Warrant Exercises
2014-12-31
2014-10-30 2128.09 未披露 定期报告 2014-09-30
2014-08-07 2113.70 未披露 定期报告 2014-08-07
2014-08-07 1557.72 未披露 定期报告 2014-06-30
2014-04-30 1475.32 未披露 定期报告 2014-03-31
2014-03-11 1471.86 未披露 定期报告 2014-03-11
2014-03-11 1470.79 未披露
更多>>
from December 31, 2012 to December 31, 2013 Stock option exercises Restricted Stock Unit Settlements
2013-12-31
2013-11-07 1470.76 未披露 定期报告 2013-11-07
2013-11-07 1470.63 未披露 定期报告 2013-09-30
2013-08-08 1468.04 未披露 定期报告 2013-06-30
2013-05-02 1467.04 未披露 定期报告 2013-05-02
2013-04-22 1467.00 未披露 定期报告 2013-03-28
2013-03-07 1465.88 未披露 定期报告 2013-03-07
2013-03-07 1465.69 未披露
更多>>
from December 31, 2011 to November 7,2012 Shares issued in March 2012 financing Stock option exercises
2012-11-07
2012-11-08 1465.64 未披露 定期报告 2012-09-30
2012-08-02 1457.35 未披露 定期报告 2012-06-30
2012-05-03 1453.99 未披露 定期报告 2012-03-31
2012-03-08 975.01 未披露 定期报告 2012-03-08
2012-03-08 974.98 未披露
更多>>
from December 31, 2010 to December 31, 2011 Stock option exercises
2011-12-31
2011-11-03 974.84 未披露 定期报告 2011-09-30
2011-08-04 972.55 未披露 定期报告 2011-08-01
2011-05-09 971.83 未披露 定期报告 2011-03-31
2011-03-10 971.45 未披露 定期报告 2011-03-04
2011-03-10 969.36 未披露
更多>>
from dec 31 2009 to dec 31 2010 Shares issued in October 2010 financing Stock option exercises
2010-12-31
2010-11-04 965.86 未披露 定期报告 2010-11-01
2010-11-04 648.05 未披露 定期报告 2010-09-30
2010-08-05 644.42 未披露 定期报告 2010-08-01
2010-08-05 644.17 未披露 定期报告 2010-06-30
2010-05-06 637.55 未披露 定期报告 2010-03-31
2010-03-08 633.37 未披露 定期报告 2010-03-04
2010-03-08 632.40 未披露
更多>>
from December 31, 2008 to December 31, 2009 Shares issued in July 2009 financing Shares issued in Teva share purchase agreement Stock option exercises
2009-12-31
2009-03-11 554.41 未披露
更多>>
from December 31, 2007 to December 31, 2008 Shares held by Sonus shareholders Shares issued in exchange for convertible debentures Shares issued in exchange for preferred shares Escrow shares released on achievement of milestones Stock option exercises Issuance of common stock under employee benefit plans On August 12, 2008, OncoGenex Technologies’ stockholders approved the Arrangement described above and on August 19, 2008, Sonus stockholders approved the Arrangement, an one-for-eighteen reverse stock split of its common stock, and a reduction of Sonus’ authorized capital from 75,000,000 common shares to 11,019,930 common shares.
2008-12-31
2008-03-14 3704.83 未披露
更多>>
from December 31, 2006 to December 31, 2007 Issuance of common stock under employee benefit plans Exercise of common stock warrants
2007-12-31
2007-03-16 3685.40 未披露
更多>>
from December 31, 2005 to December 31, 2006 Issuance of common stock under employee benefit plans Exercise of common stock warrants Issuance of common stock (net of offering costs of $2,079,549)
2006-12-31
2006-03-16 3056.57 未披露
更多>>
from December 31, 2004 to December 31, 2005 Issuance of common stock under employee benefit plans Exercise of common stock warrants Issuance of common stock and common stock warrants (net of offering costs of $1,180,669)
2005-12-31
2005-03-23 2135.28 未披露
更多>>
from December 31, 2003 to December 31, 2004 Issuance of common stock under employee benefit plans Exercise of common stock warrants Issuance of common stock (net of offering costs of $777,096)
2004-12-31
2004-03-12 1795.75 未披露
更多>>
from December 31, 2002 to December 31, 2003 Issuance of common stock under employee benefit plans Exercise of common stock warrants Issuance of common stock and common stock warrants (net of offering costs of $1,082,977)
2003-12-31
2003-03-10 1369.15 未披露
更多>>
from December 31, 2001 to December 31, 2002 Issuance of common stock (net of offering costs of $1,293,100)
2002-12-31
2002-03-05 1165.08 未披露
更多>>
from December 31, 2000 to December 31, 2001 Issuance of common stock (net of offering costs of $478,380)
2001-12-31
2001-03-07 960.35 未披露
更多>>
from December 31, 1999 to December 31, 2000 Issuance of common stock
2000-12-31
2000-02-29 899.00 未披露
更多>>
from December 31, 1998 to December 31, 1999 Issuance of common stock
1999-12-31
1999-03-25 863.22 未披露
更多>>
from December 31, 1997 to December 31, 1998 Issuance of common stock
1998-12-31
1998-03-31 861.14 未披露
更多>>
from December 31, 1996 to December 31, 1997 Issuance of common stock
1997-12-31
1997-03-19 853.09 未披露
更多>>
from December 31, 1995 to December 31, 1996 Issuance of common stock
1996-12-31
1997-03-19 844.81 未披露
更多>>
from December 31, 1994 to December 31, 1995 Initial public offering of common stock net of offering costs of $2,476,938 Conversion of redeemable preferred stock into common stock Conversion of refundable option fees into common stock Conversion of convertible subordinated debenture into common stock Issuance of common stock Repurchase of common stock
1995-12-31
Common stock offered 13,086,151 shares by the company
From June 30, 2023 to September 30, 2023 Shares issued as settlement with trade vendor
From March 31, 2023 to June 30, 2023 Shares issued - May 2023 private placement Restricted stock unit settlements withheld and retired to treasury Shares issued on exercise of warrants Restricted stock unit settlements
Common Stock Offered by the company 3,000,000 shares
From December 31, 2022 to March 31, 2023 Shares issued on exercise of warrants
From December 31, 2021 to December 31, 2022 Shares issued on exercise of warrants Shares issued from purchase agreement with Virtu Shares issued as settlement with trade vendor Restricted stock unit settlements Restricted stock unit settlements withheld and retired to treasury Shares issued under employee share purchase plan Shares issued - November 2022 private placement
From June 30, 2022 to September 30, 2022 Shares issued under employee share purchase plan
From March 31, 2022 to June 30, 2022 Shares issued from purchase agreement with Virtu Restricted stock unit settlements Restricted stock unit settlements withheld and retired to treasury
From December 31, 2021 to March 31, 2022 Shares issued on exercise of warrants Shares issued from purchase agreement with Virtu Shares issued as settlement with trade vendor
From June 30, 2021 to September 30, 2021 Shares issued on exercise of warrants Restricted stock unit settlements
From March 31, 2021 to June 30, 2021 Shares issued on exercise of warrants Shares issued as settlement with trade vendor
1.Common stock offered 2,857,143 shares. 2.The number of shares of common stock to be outstanding after this offering is based on 6,149,917 shares of common stock outstanding as of March 31, 2021.
From December 31, 2020 to March 31, 2021 Shares issued on exercise of warrants Shares issued as settlement with trade vendor
from December 31, 2019 to December 31, 2020 Shares issued on exercise of warrants Shares issued - April 2020 Private placement Shares issued - July 2020 Registered direct offering Shares issued - August 2020 Public offering Shares issued - December 2020 Public offering Restricted stock unit settlements Shares issued on conversion of Series B preferred shares Adjustment of fractional shares on reverse stock split
1.Common stock offered 2,150,000 shares. 2.The number of shares of common stock to be outstanding after this offering is based on 3,616,414 shares of common stock outstanding as of September 30, 2020.
From June 30, 2020 to September 30, 2020 Shares issued - July 2020 Registered Direct Offering Shares issued - August 2020 Public Offering Shares issued on exercise of warrants Restricted stock unit settlements Adjustment of fractional shares on reverse stock split
The Company’s board of directors has determined to set the reverse stock split ratio at 1-for-20. The effective date of the reverse stock split is July 31, 2020, and the shares will begin trading on a split-adjusted basis on July 31, 2020.
1.Common Stock Offered by the company 14,634,146 shares. 2.The number of shares of common stock to be outstanding after this offering in the table above is based on 31,352,764 shares of common stock outstanding as of March 31, 2020.
From December 31, 2019 to March 31, 2020 Shares issued on conversion of Series B preferred shares
from December 31, 2018 to December 31, 2019 Restricted stock unit settlements Shares issued - from purchase agreement with Lincoln Park Capital Shares issued - December 2019 public offering Shares issued on exercise of warrants Shares issued on conversion of Series A preferred shares Shares issued on conversion of Series B preferred shares
On December 19, 2019, the Company issued and sold (i) 12,577,504 shares of Common Stock (which includes 3,000,000 shares of Common Stock sold pursuant to the exercise of the Overallotment Option), (ii) 6,256 shares of Series B Preferred Stock and (iii) 23,000,000 Warrants (which includes 3,000,000 Warrants sold pursuant to the exercise of the Overallotment Option) pursuant to the Registration Statement and the Underwriting Agreement.
from June 30, 2019 to September 30, 2019 Restricted stock unit settlements
from March 31, 2019 to June 30, 2019 Shares issued - from purchase agreement with Lincoln Park Capital Shares issued on exercise of warrants Shares issued on conversion of preferred shares
from December 31, 2018 to March 31, 2019 Restricted stock unit settlements
from December 31, 2017 to December 31, 2018 Restricted stock unit settlements Adjustment of fractional shares on reverse stock split Shares issued - from purchase agreement with Lincoln Park Capital Shares issued - June 2018 public offering Shares issued - October 2018 registered direct offering Shares issued on exercise of warrants Shares issued on conversion of preferred shares
Achieve Life Sciences, Inc. (NASDAQ:ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisine for smoking cessation, today announced a reverse stock split of its shares of common stock at a ratio of 1-for-10. The reverse stock split will become effective on May 23, 2018, and shares will begin trading on the split-adjusted basis on the Nasdaq Capital Market under the Company's existing trading symbol "ACHV" at market open on May 24, 2018. The new CUSIP number following the reverse stock split will be 004468203.
from December 31, 2016 to December 31, 2017 Settlement of stockholder loans with related parties Shares issued on subscription Shares held by OncoGenex Shareholders Shares issued on conversion of Achieve common shares Shares cancelled on conversion of Achieve common shares Restricted Stock Unit Settlements Restricted Stock Unit Settlements withheld and retired to treasury Shares issues - Lincoln Park Capital
from December 31, 2014 to December 31, 2015 Stock option exercises Restricted Stock Unit Settlements Performance Restricted Stock Unit Settlements Performance Restricted Stock Unit Settlements withheld and retired to treasury Shares issues - Lincoln Park Capital
from December 31, 2013 to December 31, 2014 Stock option exercises Restricted Stock Unit Settlements Performance Restricted Stock Unit Settlements Performance Restricted Stock Unit Settlements withheld and retired to treasury Shares issued - ATM Financing Shares issued in July 2014 Financing Warrant Exercises
from December 31, 2012 to December 31, 2013 Stock option exercises Restricted Stock Unit Settlements
from December 31, 2011 to November 7,2012 Shares issued in March 2012 financing Stock option exercises
from December 31, 2010 to December 31, 2011 Stock option exercises
from dec 31 2009 to dec 31 2010 Shares issued in October 2010 financing Stock option exercises
from December 31, 2008 to December 31, 2009 Shares issued in July 2009 financing Shares issued in Teva share purchase agreement Stock option exercises
from December 31, 2007 to December 31, 2008 Shares held by Sonus shareholders Shares issued in exchange for convertible debentures Shares issued in exchange for preferred shares Escrow shares released on achievement of milestones Stock option exercises Issuance of common stock under employee benefit plans On August 12, 2008, OncoGenex Technologies’ stockholders approved the Arrangement described above and on August 19, 2008, Sonus stockholders approved the Arrangement, an one-for-eighteen reverse stock split of its common stock, and a reduction of Sonus’ authorized capital from 75,000,000 common shares to 11,019,930 common shares.
from December 31, 2006 to December 31, 2007 Issuance of common stock under employee benefit plans Exercise of common stock warrants
from December 31, 2005 to December 31, 2006 Issuance of common stock under employee benefit plans Exercise of common stock warrants Issuance of common stock (net of offering costs of $2,079,549)
from December 31, 2004 to December 31, 2005 Issuance of common stock under employee benefit plans Exercise of common stock warrants Issuance of common stock and common stock warrants (net of offering costs of $1,180,669)
from December 31, 2003 to December 31, 2004 Issuance of common stock under employee benefit plans Exercise of common stock warrants Issuance of common stock (net of offering costs of $777,096)
from December 31, 2002 to December 31, 2003 Issuance of common stock under employee benefit plans Exercise of common stock warrants Issuance of common stock and common stock warrants (net of offering costs of $1,082,977)
from December 31, 2001 to December 31, 2002 Issuance of common stock (net of offering costs of $1,293,100)
from December 31, 2000 to December 31, 2001 Issuance of common stock (net of offering costs of $478,380)
from December 31, 1999 to December 31, 2000 Issuance of common stock
from December 31, 1998 to December 31, 1999 Issuance of common stock
from December 31, 1997 to December 31, 1998 Issuance of common stock
from December 31, 1996 to December 31, 1997 Issuance of common stock
from December 31, 1995 to December 31, 1996 Issuance of common stock
from December 31, 1994 to December 31, 1995 Initial public offering of common stock net of offering costs of $2,476,938 Conversion of redeemable preferred stock into common stock Conversion of refundable option fees into common stock Conversion of convertible subordinated debenture into common stock Issuance of common stock Repurchase of common stock